People with higher body fat percentages tend to lose a greater proportion of fat versus lean mass
doi:10.1007/s001250050903 72
Compound class Synthetic cyclic melanocortin peptide Primary therapeutic relevance Central sexual-desire signaling Approved product VYLEESI bremelanotide injection FDA approval date June 21, 2019 Approved population Premenopausal women with acquired, generalized HSDD Not approved for Men, postmenopausal women, ED, or performance enhancement Terminology clarification: PT-141 generally refers to bremelanotide free base or the active peptide, while the approved drug product contains bremelanotide acetate in a specific sterile injectable formulation
There are many more benefits of the injections
Also, melanotan is now only available as an unregulated product over the internet
Supplementary Figure 4 Nicotine suppresses food responding similarly in wild-type and GLP-1 receptor knockout mice % Baseline number of food rewards earned by WT ( n =4) and GLP-1R KO mice ( n =9) after systemic delivery of saline or nicotine